FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

1920611000001107: Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25464901000001117 Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25465001000001117 Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40860901000001110 Erythrocin 250 tablets (Amdipharm) 500 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
54077801000001118 Erythrocin 250 tablets (Amdipharm Plc) 500 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
78817501000001111 Erythrocin 250 tablets (AMCo) 500 tablet en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
111558101000001117 Erythrocin 250 tablets (Advanz Pharma) 500 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Is a Erythromycin stearate 250mg tablets 500 tablet true Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Is pack of Erythrocin 250 tablets (Abbott Laboratories Ltd) false Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Has active ingredient Erythromycin stearate false Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Has excipient Sorbic acid false Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Has AMP Erythrocin 250 tablets (Abbott Laboratories Ltd) true Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Has specific active ingredient Erythromycin stearate true Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 500 tablet Has basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start